Article

barrons.com on 2022-05-20 23:41

Sanofi Receives Another Approval for Blockbuster Drug Dupixent2 min read

The go-ahead covers a chronic inflammatory disease for which the Food and Drug Administration has never before approved a treatment.

Related news